Location

Please check the individual session for location or broadcast availability.  

Frequency

Semi-monthly

Series Director

Layla Abushamat, MD, MPH

Series Co-Director

Michael Fordis, MD

Target Audience and Needs

Cardiologists, endocrinologists, and clinical geneticists need to receive regular updates on technological advances in genetic testing for cardiovascular, cardiometabolic, and related diseases.  This series will focus on case discussions among faculty involved in the Cardiometabolic Genome Project at Baylor College of Medicine and clinical specialists and subspecialists affiliated with DHR Health in the Rio Grande Valley who are participating in the Cardiometabolic Precision Health Pilot in South Texas.  The aim of the series is to enhance knowledge of cardiometabolic genetic testing, promote the application of genomic medicine tools in clinical settings, overcome barriers to point-of-care genetic counseling and testing, advance cardiovascular and cardiometabolic care, and improve patient outcomes.

Educational Methods

Educational methods will include lectures, case presentations, and panel discussion.

Objectives

At the conclusion of the session, the participants should be able to:

• Identify appropriate patient cases for cardiometabolic genetic testing.
• Interpret a genetic report, including the results of the gene panel, lipoprotein (a) variants identified, and the pharmacogenomics related to cardiometabolic care.
• Counsel a patient on the results of a cardiometabolic genetic report.

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator